Submitted by Anonymous (not verified) on 2 October 2024 - 12:30
Opinion/decision on a Paediatric investigation plan (PIP): Cometriq, cabozantinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0309/2023
Source: